Evidence map›Paper›PMID 36636702›Full record

ArticleJournal of asthma and allergy2023

Relationship Between Asthma Control as Measured by the Asthma Impairment and Risk Questionnaire (AIRQ) and Patient Perception of Disease Status, Health-Related Quality of Life, and Treatment Adherence.

Joan Reibman, Bradley E Chipps, Robert S Zeiger, David A Beuther, Robert A Wise, William McCann, Ileen Gilbert, James M Eudicone, Hitesh N Gandhi, Gale Harding and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of asthma and allergy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 1 country.

Joan ReibmanNew York University School of Medicine, New York, NY, USA.
Bradley E ChippsCapital Allergy & Respiratory Disease Center, Sacramento, CA, USA.
Robert S ZeigerDepartment of Clinical Science Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
David A BeutherNational Jewish Health, Denver, CO, USA.ORCID 0000-0002-5021-5734
Robert A WiseDivision of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-8353-2349
William McCannAllergy Partners, Asheville, NC, USA.
Ileen GilbertBioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.ORCID 0000-0003-3529-0186
James M EudiconeBioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.ORCID 0000-0001-7020-2490
Hitesh N GandhiBioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA.
Gale HardingEvidera, Bethesda, MD, USA.
Katelyn CuttsEvidera, Bethesda, MD, USA.
Karin S CoyneEvidera, Bethesda, MD, USA.
Kevin R MurphyBoys Town National Research Hospital, Boys Town, NE, USA.
Maureen GeorgeOffice of Research & Scholarship, Columbia University School of Nursing, New York, NY, USA.ORCID 0000-0001-9234-7842
AstraZeneca (United States) · USIthaka Harbors · USBoys Town National Research Hospital · USCapital Allergy and Respiratory Disease Center · USColumbia University · USENT and Allergy · USJohns Hopkins University · USKaiser Permanente · USNational Jewish Health · USNew York University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Critical asthma outcomes highlighted in clinical guidelines include asthma-related quality of life, asthma exacerbations, and asthma control. An easy-to-implement measure of asthma control that assesses both symptom impairment and exacerbation risk and reflects the impact of asthma on patients' lives is lacking. Hence, the objective of this study was to assess the Asthma Impairment and Risk Questionnaire (AIRQ Patients and methods: Baseline data were analyzed from patients (aged ≥ 12 years) with asthma participating in a 12-month observational study assessing the ability of AIRQ to predict exacerbations. At entry, patients completed a sociodemographic questionnaire, AIRQ, 3 questions addressing self-perceived asthma status, Saint George's Respiratory Questionnaire (SGRQ), mini-Asthma Quality of Life Questionnaire (AQLQ), and Adult Asthma Adherence Questionnaire (AAAQ). Descriptive statistics were calculated for demographic and clinical characteristics. AIRQ construct validity was evaluated by assessing correlations between total AIRQ score and patient self-assessments, SGRQ, mini-AQLQ, and AAAQ scores. Comparisons of SGRQ, mini-AQLQ, and AAAQ total and component/domain scores by AIRQ control category were performed using general linear models and Scheffe's post hoc adjustments for pairwise comparisons. Results: A total of 1112 patients were enrolled: 70% female, 78% White, mean (standard deviation) age 43.9 (19.5) years. There were highly significant correlations between AIRQ score and patient self-perception of overall control (r = 0.69; p < 0.001), total SGRQ (r = 0.74, p < 0.001), and mini-AQLQ (r = -0.78, p < 0.001) scores. As AIRQ control category worsened, so did total and domain SGRQ, mini-AQLQ, and AAAQ impediment-to-inhaled-corticosteroid-adherence scores (all pairwise comparisons p < 0.001). Conclusion: Findings demonstrate the construct validity of AIRQ relative to patient self-perception of asthma status, disease-specific PRO measures, and treatment adherence barriers. AIRQ can be a useful instrument to raise awareness of the unrecognized impacts of asthma on patients' lives.

Indexed as

construct validityexacerbationimpact of asthmapatient-reported outcomes

Identifiers

PMID36636702
PMCPMC9829987
OpenAlexW4313589303

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.